COVIDOM: Longterm Morbidity of SARS-CoV-2 Infection and COVID-19 Disease - Consequences for Health Status and Quality of Life (NAPKON-POP)
Status: Recruiting
Location: See all (3) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY
COVID-19 is a novel disease caused by SARS-CoV-2 that primarily affects the lungs but also various other organs of the body already in early stages of the disease. Due to the multiple organ involvements in the acute phase, it is conceivable that - in a significant proportion of patients - longterm sequels in various organ systems might occur, thereby impacting the individual's health status and quality of life; and posing a relevant burden to the resources of the health care system Assessment of SARS-CoV-2-longterm morbidity and sequels on the population level: In order to identify and treat these sequels in a timely fashion and to get a sense of the prevalence of such SARS-CoV-2 sequels on the population level, it is important to collect follow-up data and to comprehensively re-examine a population-representative sample of SARS-CoV-2 infected individuals. Within the COVIDOM study we will conduct deep clinical and biochemical phenotyping in population-representative samples in Germany. This will allow novel insights into disease pathogenesis and chronicity of virus infections.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• PCR-confirmed SARS-CoV-2 infection
• living in one of the target areas
• age at least 18 years
• written informed consent
Locations
Other Locations
Germany
University Hospital Charité Berlin
NOT_YET_RECRUITING
Berlin
University Hospital Schleswig-Holstein, Campus Kiel
RECRUITING
Kiel
University Hospital Wuerzburg
NOT_YET_RECRUITING
Würzburg
Contact Information
Primary
Stefan Schreiber, Prof. Dr.
s.schreiber@mucosa.de
0049 (0)431 500 22201
Backup
Thomas Bahmer, Prof. Dr.
thomas.bahmer@uksh.de
0049 (0) 431 500 62629
Time Frame
Start Date:2020-11-16
Estimated Completion Date:2030-12-31
Participants
Target number of participants:2000
Treatments
Populationbased Platform (POP) of the National Pandemic Cohort Network (NAPKON)
Streamlined sampling of biomaterials and core data elements (GErman Corona COnsensu data set, GECCO) with other NAPKON study platforms (HAP, SUEP).
High-Resolution Platform (HAP) of the National Pandemic Cohort Network (NAPKON)
Streamlined sampling of biomaterials and core data elements (GErman Corona COnsensu data set, GECCO) with other NAPKON study platforms (POP, SUEP).
Intersectoral Platform (SUEP) of the National Pandemic Cohort Network (NAPKON)
Streamlined sampling of biomaterials and core data elements (GErman Corona COnsensu data set, GECCO) with other NAPKON study platforms (HAP, POP).